Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.6.a
Macrì S et al. (2016)
|
Xla Wt + hmga2 + msx1
NF16 (in situ hybridization)
|
|
|
|
fig.6.c
Macrì S et al. (2016)
|
Xla Wt + hmga2 + snai2
NF16 (in situ hybridization)
|
|
|
|
fig.5.b
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.S6.b
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF22-25 (in situ hybridization)
|
|
|
|
fig.2.h
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF26-28 (in situ hybridization)
|
|
|
|
fig.2.h
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF26-28 (in situ hybridization)
|
|
|
|
fig.S6.a
Macrì S et al. (2016)
|
Xla Wt + hmga2-EnR
NF25 (in situ hybridization)
|
|
|
|
fig.4. v
Macrì S et al. (2016)
|
Xla Wt + msx1
NF16 (in situ hybridization)
|
|
|
|
fig.6.a
Macrì S et al. (2016)
|
Xla Wt + msx1
NF16 (in situ hybridization)
|
|
|
|
fig.4. s
Macrì S et al. (2016)
|
Xla Wt + msx1 MO
NF16 (in situ hybridization)
|
|
|